{"id":6282,"date":"2014-05-02T13:04:34","date_gmt":"2014-05-02T12:04:34","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=6282"},"modified":"2014-05-02T13:04:34","modified_gmt":"2014-05-02T12:04:34","slug":"un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","title":{"rendered":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n"},"content":{"rendered":"\n<p>\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la Immunoter\u00e0pia. Gasc\u00f3n es va referir als resultats obtinguts a trav\u00e9s d\u2019aquesta ter\u00e0pia com \u201cesperan\u00e7adors\u201d (va parlar de melanoma, c\u00e0ncer de pulm\u00f3 i c\u00e0ncer renal) tot i que \u201ccaldr\u00e0 revisar tots els estudis que s\u2019estan realitzant\u201d. Pere Gasc\u00f3n, cap d\u2019Oncologia m\u00e8dica de l\u2019Hospital Cl\u00ednic de Barcelona, va parlar de \u201crespostes de fins a un 60% i d\u2019un 20-30% de llarga durada\u201d.<\/p>\n<p>En el v\u00eddeo adjunt el Dr. Gasc\u00f3n, tamb\u00e9 responsable del Laboratori d\u2019Oncologia <a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-09.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-6288\" alt=\"C\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-09.jpg\" width=\"306\" height=\"204\" \/><\/a>Molecular i Transnacional de l\u2019Hospital Cl\u00ednic, ens defineix qu\u00e8 \u00e9s la immunoter\u00e0pia, qu\u00e8 ha fet possible aquesta ter\u00e0pia i qu\u00e8 s\u2019ha descobert estudiant l\u2019entorn del tumor. Tamb\u00e9 destaca que \u00e9s important<b> la informaci\u00f3 als malalts sobre els f\u00e0rmacs, la pauta d\u2019administraci\u00f3, els efectes secundaris, etc. i el paper del farmac\u00e8utic al respecte, aix\u00ed com pel que fa a la prevenci\u00f3 del c\u00e0ncer.<\/b><\/p>\n<p>Gasc\u00f3n va parlar dels limf\u00f2cits infiltrants del tumor (TILs), que han tornat a recuperar la fama que varen tenir als anys vuitanta, dels limf\u00f2cits T que expressen uns receptors quimera (CARTs), amb resultats positius en leuc\u00e8mies d\u2019adults i infants, i tamb\u00e9 dels inhibidors dels check points del sistema immunol\u00f2gic. Tot plegat fa que, segons ell, estiguem vivint &#8220;un moment revolucionari i un canvi de paradigma en el tractament del c\u00e0ncer&#8221;.<\/p>\n<figure id=\"attachment_6290\" aria-describedby=\"caption-attachment-6290\" style=\"width: 510px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-16.jpg\"><img decoding=\"async\" class=\" wp-image-6290\" alt=\"C\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-16.jpg\" width=\"510\" height=\"341\" \/><\/a><figcaption id=\"caption-attachment-6290\" class=\"wp-caption-text\">Un cop m\u00e9s, la sala d&#8217;actes del Col\u00b7legi es va omplir de farmac\u00e8utics per a aquesta Tert\u00falia d&#8217;actualitat sobre Immunoter\u00e0pia (16 d&#8217;abril). Francisca Aranzana, vocal d&#8217;Oficina de farm\u00e0cia, va presentar el conferenciant, el Dr. Pere Gasc\u00f3n.<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70],"class_list":["post-6282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-02T12:04:34+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n\",\"datePublished\":\"2014-05-02T12:04:34+00:00\",\"dateModified\":\"2014-05-02T12:04:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"},\"wordCount\":372,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\",\"name\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-05-02T12:04:34+00:00\",\"dateModified\":\"2014-05-02T12:04:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","og_locale":"ca_ES","og_type":"article","og_title":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-05-02T12:04:34+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n","datePublished":"2014-05-02T12:04:34+00:00","dateModified":"2014-05-02T12:04:34+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"},"wordCount":372,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","url":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","name":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-05-02T12:04:34+00:00","dateModified":"2014-05-02T12:04:34+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/6282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=6282"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/6282\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=6282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=6282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=6282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}